Sheelu Varghese, Zhaorong Chen, David L. Bartlett, James F. Pingpank, Steven K. Libutti, Seth M. Steinberg, John Wunderlich and H. Richard Alexander Jr. Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma Cancer 117
Article first published online: 13 SEP 2010 | DOI: 10.1002/cncr.25555
Malignant peritoneal mesothelioma (MPM) is an understudied cancer. In this study, the authors investigated the molecular nature of MPM to obtain insights into the heterogeneity of its clinical behavior and to identify new therapeutic targets for intervention.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.